Andy-
Do you cap the cumulative percent effort that they can spend on P30βs?
Thanks,
Judy
From: Core Administrators Network Forum <email obscured>] On Behalf
Of Andrew Chitty
Sent: Wednesday, October 23, 2019 1:26 PM
To: <email obscured>
Subject: [BULK][EXT] Re: [core administrators network forum] Core Directors on
NIH grants
OSHU is similar to VUMC as outlined by Susan below. We strongly discourage
(pretty much donβt allow) R01 for core staff, although we do allow P30s.
Andy
Andy Chitty
Director | University Shared Resources
<https://www.ohsu.edu/xd/research/research-cores/<https://www.ohsu.edu/xd/research/research-cores/>>
Oregon Health and Science University
Phone: 503.494.5887
<email obscured><email obscured>>
On 10/23/19, 5:42 AM, "Core Administrators Network Forum on behalf of Meyn,
Susan M" <email obscured> on behalf of
<email obscured><email obscured><email obscured>>>
wrote:
Hi Judy,
At VUMC we discourage effort on R01 type grants for core staff (all non faculty
positions). If it does occur, we require a justification that differentiates
and distinguishes the grant funded activities from the services provided by the
core. For the most part, we consider experimental design to be part of a given
core service, so that would not be sufficient justification for grant funding,
as one example.
We do allow core staff to have effort on P30s and on core components of P50s.
Susan
> On Oct 22, 2019, at 8:36 PM, J Drazba
<email obscured><email obscured>>> wrote:
>
> Hi everyone,
>
> Some of our full-time Core Directors have staff level positions, meaning
Assistant., Associate., or Full Professor equivalent rank. Our leadership is
trying to determine if such people could have a percent effort on NIH grants
such as R01's. Since our Director's salaries are included in our Core budgets
it would reduce the burden. My questions are:
>
> 1. How much effort is acceptable? Even if they limit participation to
5%/grant, how many grants could they reasonably participate in?
> 2. What should the investigators get in return? Should the funding be for
intellectual contribution in designing experiments and analyzing data or could
it include the use of equipment and/or consumables?
>
> Any experience or advice will be greatly appreciated.
>
> Thanks,
> Judy Drazba
> Cleveland Clinic Lerner Research Institute
>
> ββ
> View topic
https://nam05.safelinks.protection.outlook.com/?url=http%3A%2F%2Flist.abrf.org%2Fr%2Ftopic%2F24vuCOi9q8OtBARAqWRcCF&data=02%7C01%7Cs.meyn%40vumc.org%7C275ac8fe218c40c914c708d757596497%7Cef57503014244ed8b83c12c533d879ab%7C0%7C1%7C637073913758667789&sdata=isvsNQ7zvlN3n6DRvxqthkhZJSubc%2Fq5glKX%2FGjO%2FnY%3D&reserved=0<https://nam05.safelinks.protection.outlook.com/?url=http%3A%2F%2Flist.abrf.org%2Fr%2Ftopic%2F24vuCOi9q8OtBARAqWRcCF&data=02%7C01%7Cs.meyn%40vumc.org%7C275ac8fe218c40c914c708d757596497%7Cef57503014244ed8b83c12c533d879ab%7C0%7C1%7C637073913758667789&sdata=isvsNQ7zvlN3n6DRvxqthkhZJSubc%2Fq5glKX%2FGjO%2FnY%3D&reserved=0>
> Leave group <email obscured>?Subject=Unsubscribe
>
ββ
View topic
http://list.abrf.org/r/topic/1MGwmwJ0yCEjDCMVCyucay<http://list.abrf.org/r/topic/1MGwmwJ0yCEjDCMVCyucay>
Leave group <email obscured>?Subject=Unsubscribe
Rest of post
ββ
View topic
http://list.abrf.org/r/topic/3zRCtsKJfZEuGgvNUxSyqZ<http://list.abrf.org/r/topic/3zRCtsKJfZEuGgvNUxSyqZ>
Leave group <email obscured>?Subject=Unsubscribe
Please consider the environment before printing this e-mail
Cleveland Clinic is currently ranked as the No. 2 hospital in the country by
U.S. News & World Report (2017-2018). Visit us online at
http://www.clevelandclinic.org for a complete listing of our services, staff
and locations. Confidentiality Note: This message is intended for use only by
the individual or entity to which it is addressed and may contain information
that is privileged, confidential, and exempt from disclosure under applicable
law. If the reader of this message is not the intended recipient or the
employee or agent responsible for delivering the message to the intended
recipient, you are hereby notified that any dissemination, distribution or
copying of this communication is strictly prohibited. If you have received this
communication in error, please contact the sender immediately and destroy the
material in its entirety, whether electronic or hard copy. Thank you.